Study of viral safety of Scottish National Blood Transfusion Service factor VIII/IX concentrate
- 1 December 1993
- journal article
- Published by Wiley in Transfusion Medicine
- Vol. 3 (4), 295-298
- https://doi.org/10.1111/j.1365-3148.1993.tb00065.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non‐virus inactivated factor VIII and IX concentratesBritish Journal of Haematology, 1992
- Revision of the Protocol Recommended for Studies of Safety from Hepatitis of Clotting Factor ConcentratesThrombosis and Haemostasis, 1989
- Factor concentrates for treatment of hemophilia: which one to choose? [see comments]Blood, 1989
- HUMAN T-LYMPHOTROPIC VIRUS TYPE III (HTLV-III) INFECTION IN SERONEGATIVE HAEMOPHILIACS AFTER TRANSFUSION OF FACTOR VIIIThe Lancet, 1985
- High risk of non‐A non‐B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulinBritish Journal of Haematology, 1985
- Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients.BMJ, 1983
- Incidence of infection with hepatitis B virus in 56 patients with haemophilia A 1971-1979.Journal of Clinical Pathology, 1983
- If Nothing Goes Wrong, Is Everything All Right?JAMA, 1983
- Antibody to hepatitis B antigen in haemophiliacs and their household contactsJournal of Clinical Pathology, 1974